Jeppson Wealth Management LLC reduced its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 26.4% in the 4th quarter, HoldingsChannel reports. The fund owned 4,832 shares of the pharmacy operator’s stock after selling 1,735 shares during the quarter. Jeppson Wealth Management LLC’s holdings in CVS Health were worth $217,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new position in CVS Health in the third quarter valued at approximately $25,000. Ridgewood Investments LLC boosted its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health in the third quarter valued at $31,000. Finally, Reston Wealth Management LLC acquired a new position in CVS Health in the third quarter valued at $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
Wall Street Analyst Weigh In
CVS has been the topic of a number of research analyst reports. Royal Bank of Canada cut their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. Evercore ISI increased their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday. Truist Financial cut their target price on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Mizuho decreased their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $68.12.
CVS Health Price Performance
CVS Health stock opened at $56.20 on Tuesday. The company has a market cap of $70.72 billion, a P/E ratio of 14.26, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The business has a fifty day moving average of $51.24 and a two-hundred day moving average of $56.20. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. As a group, analysts predict that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.
CVS Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.73%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- What is a Low P/E Ratio and What Does it Tell Investors?
- What Does the Future Hold for Eli Lilly?
- How to Effectively Use the MarketBeat Ratings Screener
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.